Skip to main content
Log in

Vitamin D3 in Patients with Various Grades of Chronic Pancreatitis, According to Morphological and Functional Criteria of the Pancreas

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

There are still too few conclusive reports about conspicuous vitamin D deficiency in patients with chronic pancreatitis, or any connection of the deficiency to the severity of the disease. Between October 1999 and September 2000, we investigated 42 patients at an average age of 53 years, suffering from chronic pancreatits, as well as 20 healthy male controls at an average age of 49 years. Serum levels of D3 vitamins, 1,25-(OH)2-vitamin D3 and 25-(OH)-vitamin D3, as well as the concentration of fecal elastase 1 were determined in patients and controls. Furthermore, the severity of chronic pancreatitis in patients was determined via endoscopic retrograde cholangiopancreatography (ERCP) into 3 grades, based on the Cambridge classification. Elastase 1 in feces revealed sensitivities of 14%, 87%, and 95% for Cambridge-grades I, II, and III, respectively, and correlated significantly with this classification of severity of chronic pancreatitis (P < 0.01). In patients with Cambridge-grade II and III 1,25-(OH)2-D3 was markedly decreased (26.7 ± 7.7 pg/ml and 27.6 ± 9.0 pg/ml) compared to those with Cambridge-grade I (38.0 ± 10.5 pg/ml; between I and II P = 0.027, between I and III P = 0.033). 25-(OH)-D-3 did not differ significantly within the various Cambridge-grade groups (P = 0.07). Nevertheless, vitamin D3 and fecal elastase 1 in patients correlated significantly (P < 0.01) and, compared to controls, both were extremely low (means in patients: fecal elastase 1 140.7 ± 75.7 μ g/g, 1,25-(OH)2-D3 29.9 ± 9.5 pg/ml, 25-(OH)-D3 26.7 ± 9.7 nmol/liter; controls: fecal elastase 1 694.9 ± 138.6 μ g/g, 1,25-(OH)2-D3 67.5 ± 4.3 pg/ml, 25-(OH)-D3 69.5 ± 13.5 nmol/liter). The amounts of both D3 vitamins in patients were significantly lower when the content of fecal elastase 1 was under 200 μ g/g compared to the others [for 1,25-(OH)2-D3 P < 0.01, for 25-(OH)-D3 P < 0.05]. Therefore, ERCP and fecal elastase 1 verify the severity grade of a chronic pancreatitis, and thus show a vitamin D3 deficiency, depending on the progress of the disease. There seems to be a connection between inflammatory pancreas destruction (Cambridge classification), exocrine insufficiency (fecal elastase 1), and perhaps even the characteristics of sterol-binding of pancreatic elastase 1, which seems to be relevant for vitamin D supply.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Steer ML, Waxman I, Freedman S: Chronic pancreatitis. N Engl J Med 332(22):1482-1490, 1995

    Google Scholar 

  2. Manes G, Kahl S, Glasbrenner B, Malfertheiner P: Chronic pancreatitis: diagnosis and staging. Ann Ital Chir 71(1):23-32, 2000

    Google Scholar 

  3. Sarner M, Cotton PB: Classification of pancreatitis. Gut 25(7):756-759, 1984

    Google Scholar 

  4. Löser C, Möllgaard A, Fölsch UR: Faecal elastase 1: a novel, highly sensitive, and specific tubeless pancreatic function test. Gut 39(4):580-586, 1996

    Google Scholar 

  5. Bozkurt T, Braun U, Leferink S, Gilly G, Lux G: Comparison of pancreatic morphology and exocrine functional impairment in patients with chronic pancreatitis. Gut 35(8):1132-1136, 1994

    Google Scholar 

  6. Dominguez-Munoz JE, Hieronymus C, Sauerbruch T, Malfertheiner P: Fecal elastase test: evaluation of a new noninvasive pancreatic function test. Am J Gastroenterol 90(10):1834-1837, 1995

    Google Scholar 

  7. Glasbrenner B, Schon A, Klatt S, Beckh K, Adler G: Clinical evaluation of the faecal elastase test in the diagnosis and staging of chronic pancreatitis. Eur J Gastroenterol Hepatol 8(11):1117-1120, 1996

    Google Scholar 

  8. Dutta SK, Bustin MP, Russell RM, Costa BS: Deficiency of fat-soluble vitamins in treated patients with pancreatic insufficiency. Ann Intern Med 97(4):549-552, 1982

    Google Scholar 

  9. Dibble JB, Sheridan P, Losowsky MS: A survey of vitamin D deficiency in gastrointestinal and liver disorders. Q J Med 53(209):119-134, 1984

    Google Scholar 

  10. Nakamura T, Takebe K, Imamura K, Tando Y, Yamada M, Arai Y, Ishii M, Kikuchi H, Suda T: Fat-soluble vitamins in patients with chronic pancreatitis (pancreatic insufficiency). Acta Gastroenterol Belg 59(1):10-14, 1996

    Google Scholar 

  11. Moran CE, Sosa EG, Martinez SM, Geldem P, Messina P, Russo A, Boerr L, Bai JC: Bone mineral density in patients with pancreatic insufficiency and steatorrhea. Am J Gastroenterol 92(5):867-871, 1997

    Google Scholar 

  12. Haaber AB, Rosenfalck AM, Hansen B, Hilsted J, Larsen S: Bone mineral metabolism, bone mineral density, and body composition in patients with chronic pancreatitis and pancreatic exocrine insufficiency. Int J Pancreatol 27(1):21-27, 2000

    Google Scholar 

  13. Dufner J, Jensen U, Schumacher E: Statistik mit SAS. 1 ed. Stuttgart: Teubner-Verlag, 1992, 173pp

    Google Scholar 

  14. Sachs L: Angewandte Statistik. 7 ed. Berlin, Springer-Verlag, 1997, 511pp

    Google Scholar 

  15. Scharla SH, Lempert UG, Kamilli I: Inflammation mediated osteopenia (IMO): therapeutic effect of D-hormone and the role of cytokines. Z Rheumatol 59(Suppl 1):21-23, 2000

    Google Scholar 

  16. Poskitt EM, Cole TJ, Lawson DE: Diet, sunlight, and 25-hydroxy vitamin D in healthy children and adults. Br Med J 1(6158):221-223, 1979

    Google Scholar 

  17. Twersky Y, Bank S: Nutritional deficiencies in chronic pancreatitis. Gastroenterol Clin North Am 18(3):543-565, 1989

    Google Scholar 

  18. DiMagno EP, Go VL, Summerskill WH: Relations between pancreatic enzyme ouputs and malabsorption in severe pancreatic insufficiency. N Engl J Med 288(16):813-815, 1973

    Google Scholar 

  19. Krawatt EL, Maner EB, Davies M: Absorption of vitamin D and 25-OH vitamin D in patients with intestinal malabsorption. In AW Norman, K Schaefer, DV Herrath, et al (eds). Vitamin D, Basic Research and its Clinical Application, 1 ed. Berlin, Gruyter-Verlag, 1979, pp 975-978

    Google Scholar 

  20. Sziegoleit A, Linder D: Studies on the sterol-binding capacity of human pancreatic elastase 1. Gastroenterology 100(3):768-774, 1991

    Google Scholar 

  21. Schmidt-Gayk H, Thomas L, Stracke H: Mineralhaushalt und Nebenschilddrüse. In L Thomas, (ed). Labor und Diagnose, 4th ed. Marburg, Die Medizinische Verlagsgesellschaft, 1992, pp 342-379

    Google Scholar 

  22. Scharla SH, Scheidt-Nave C, Leidig G, Woitge H, Wuster C, Seibel MJ, Ziegler R: Lower serum 25-hydroxyvitamin D is associated with increased bone resorption markers and lower bone density at the proximal femur in normal females: a population-based study. Exp Clin Endocrinol Diabetes 104(3):289-292, 1996

    Google Scholar 

  23. Chapuy MC, Chapuy P, Thomas JL, Hazard MC, Meunier PJ: Biochemical effects of calcium and vitamin D supplementation in elderly, institutionalized, vitamin D-deficient patients. Rev Rheum Engl Ed 63(2):135-140, 1996

    Google Scholar 

  24. Prost A, Rambaud JC, Cottin S, Bernier JJ: Chronic pancreatitis and osteomalacia. Biol Gastroenterol (Paris) 2:161-166, 1970

    Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mann, S., Stracke, H., Lange, U. et al. Vitamin D3 in Patients with Various Grades of Chronic Pancreatitis, According to Morphological and Functional Criteria of the Pancreas. Dig Dis Sci 48, 533–538 (2003). https://doi.org/10.1023/A:1022540816990

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1022540816990

Navigation